We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current NEO market cap is 1.78B. The company's latest EPS is USD -0.6894 and P/E is -20.12.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 128.78M | 138.71M | 137.22M | 146.92M | 151.95M |
| Operating Income | -39.51M | -26.38M | -35.07M | -29.89M | -24.2M |
| Net Income | -36.85M | -22.69M | -30.8M | -24.33M | -18.52M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 408.83M | 444.45M | 484.33M | 509.73M | 591.64M |
| Operating Income | 13.01M | -13.99M | -118.75M | -157.62M | -107.74M |
| Net Income | 8.01M | 4.17M | -8.35M | -144.25M | -87.97M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.76B | 1.74B | 1.71B | 1.7B | 1.68B |
| Total Liabilities | 742.59M | 742.01M | 734.71M | 738.92M | 730.81M |
| Total Equity | 1.01B | 998.02M | 974.46M | 956.19M | 947.43M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 709.51M | 988.33M | 1.87B | 1.74B | 1.68B |
| Total Liabilities | 202.1M | 294.04M | 761.5M | 742.01M | 739.69M |
| Total Equity | 507.41M | 694.29M | 1.11B | 998.02M | 941.54M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -62.31M | -65.99M | -12.69M | -14.24M | -19.74M |
| Investing | 1.58M | 517k | 23.74M | 38.69M | 59.51M |
| Financing | 10.03M | 11.83M | 1.38M | 1.44M | 3.28M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 23.37M | 1.46M | -26.72M | -65.99M | -1.95M |
| Investing | -19.63M | -159.44M | -632.37M | 517k | 76.71M |
| Financing | 159.47M | 235.6M | 725.29M | 11.83M | 4.55M |
| Market Cap | 1.78B |
| Price to Earnings Ratio | -20.12 |
| Price to Sales Ratio | 2.99 |
| Price to Cash Ratio | 5.17 |
| Price to Book Ratio | 1.88 |
| Dividend Yield | - |
| Shares Outstanding | 127.61M |
| Average Volume (1 week) | 774.44k |
| Average Volume (1 Month) | 661.56k |
| 52 Week Change | -8.76% |
| 52 Week High | 21.22 |
| 52 Week Low | 11.03 |
| Spread (Intraday) | 0.62 (4.28%) |
| Company Name | NeoGenomics Inc |
| Address |
112 north curry street carson city, nevada 89703 |
| Website | https://www.neogenomics.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
